270
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Effects of Black Raspberries and Their Constituents on Rat Prostate Carcinogenesis and Human Prostate Cancer Cell Growth In Vitro

, , &
Pages 672-685 | Received 12 Jul 2019, Accepted 26 Jul 2019, Published online: 12 Aug 2019

References

  • Siegel RL, Miller KD, and Jemal A: Cancer statistics, 2019. CA A Cancer J Clin 69, 7–34, 2019.
  • Stan SD, Kar S, Stoner GD, and Singh SV: Bioactive food components and cancer risk reduction. J Cell Biochem 104, 339–356, 2008.
  • Stoner GD: Foodstuffs for preventing cancer: the preclinical and clinical development of berries. Cancer Prev Res (Phila) 2, 187–194, 2009.
  • Kula M, and Krauze-Baranowska M: Rubus occidentalis: the black raspberry-its potential in the prevention of cancer. Nutr Cancer 68, 1–11, 2016.
  • Chen T, Rose ME, Hwang H, Nines RG, and Stoner GD: Black raspberries inhibit N-nitrosomethylbenzylamine (NMBA)-induced angiogenesis in rat esophagus parallel to the suppression of COX-2 and iNOS. Carcinogenesis 27, 2301–2307, 2006.
  • Stoner GD, Chen T, Kresty LA, Aziz RM, Reinemann T, et al.: Protection against esophageal cancer in rodents with lyophilized berries: potential mechanisms. Nutr Cancer 54, 33–46, 2006.
  • Kresty LA, Morse MA, Morgan C, Carlton PS, Lu J, et al.: Chemoprevention of esophageal tumorigenesis by dietary administration of lyophilized black raspberries. Cancer Res 61, 6112–6119, 2001.
  • Harris GK, Gupta A, Nines RG, Kresty LA, Habib SG, et al.: Effects of lyophilized black raspberries on azoxymethane-induced colon cancer and 8-hydroxy-2'-deoxyguanosine levels in the Fischer 344 rat. Nutr Cancer 40, 125–133, 2001.
  • Aiyer HS and Gupta RC: Berries and ellagic acid prevent estrogen-induced mammary tumorigenesis by modulating enzymes of estrogen metabolism. Cancer Prev Res 3, 727–737, 2010.
  • Aiyer HS, Srinivasan C, and Gupta RC: Dietary berries and ellagic acid diminish estrogen-mediated mammary tumorigenesis in ACI rats. Nutr Cancer 60, 227–234, 2008.
  • Ravoori S, Vadhanam MV, Aqil F, and Gupta R: Inhibition of estrogen-mediated mammary tumorigenesis by blueberry and black raspberry. J Agric Food Chem 60, 5547–5555, 2012.
  • Ceci C, Tentori L, Atzori MG, Lacal PM, Bonanno E, et al.: Ellagic acid inhibits bladder cancer invasiveness and in vivo tumor growth. Nutrients 8, pii, 744, 2016.
  • Kresty LA, Mallery SR, and Stoner GD: Black raspberries in cancer clinical trials: past, present and future. J Berry Res 6, 251–261, 2016.
  • Lu H, Li J, Zhang D, Stoner GD, and Huang C: Molecular mechanisms involved in chemoprevention of black raspberry extracts: from transcription factors to their target genes. Nutr Cancer 54, 69–78, 2006.
  • Wang LS, Hecht SS, Carmella SG, Yu N, Larue B, et al.: Anthocyanins in black raspberries prevent esophageal tumors in rats. Cancer Prev Res (Phila) 2, 84–93, 2009.
  • Wang LS, Hecht S, Carmella S, Seguin C, Rocha C, et al. Berry ellagitannins may not be sufficient for prevention of tumors in the rodent esophagus. J Agric Food Chem 58, 3992–3995, 2010.
  • Ross HA, McDougall GJ, and Stewart D: Antiproliferative activity is predominantly associated with ellagitannins in raspberry extracts. Phytochem 68, 218–228, 2007.
  • Wu X, Beecher GR, Holden JM, Haytowitz DB, Gebhardt SE, et al.: Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption. J Agric Food Chem 54, 4069–4075, 2006.
  • Aiyer HS, Kichambare S, and Gupta RC: Prevention of oxidative DNA damage by bioactive berry components. Nutr Cancer 60, 36–42, 2008.
  • Landete JM: Ellagitannins, ellagic acid and their derived metabolites: a review about source, metabolism, functions and health. Food Res Intl 44, 1150–1160, 2011.
  • Kang I, Buckner T, Shay NF, Gu L, and Chung S: Improvements in metabolic health with consumption of ellagic acid and subsequent conversion into urolithins: evidence and mechanisms. Adv Nutr 7, 961–972, 2016.
  • Heber D: Multitargeted therapy of cancer by ellagitannins. Cancer Lett 269, 262–268, 2008.
  • Wang L, Ho J, Glackin C, and Martins-Green M: Specific pomegranate juice components as potential inhibitors of prostate cancer metastasis. Transl Oncol 5, 344–355, 2012.
  • Galvano F, La Fauci L, Lazzarino G, Fogliano V, Ritieni A, et al.: Cyanidins: metabolism and biological properties. J Nutr Biochem 15, 2–11, 2004.
  • Wang L-S and Stoner GD: Anthocyanins and their role in cancer prevention. Cancer Lett 269, 281–290, 2008.
  • Chen PN, Chu SC, Chiou HL, Chiang CL, Yang SF, et al.: Cyanidin 3-glucoside and peonidin 3-glucoside inhibit tumor cell growth and induce apoptosis in vitro and suppress tumor growth in vivo. Nutr Cancer 53, 232–243, 2005.
  • Rodrigo KA, Rawal Y, Renner RJ, Schwartz SJ, Tian Q, et al.: Suppression of the tumorigenic phenotype in human oral squamous cell carcinoma cells by an ethanol extract derived from freeze-dried black raspberries. Nutr Cancer 54, 58–68, 2006.
  • Seeram NP, Adams LS, Zhang Y, Lee R, Sand D, et al.: Blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry extracts inhibit growth and stimulate apoptosis of human cancer cells in vitro. J Agric Food Chem 54, 9329–9339, 2006.
  • Aura A-M, Martin-Lopez P, O’Leary KA, Williamson G, Oksman-Caldentey K-M, et al.: In vitro metabolism of anthocyanins by human gut microflora. Eur J Nutr 44, 133–142, 2005.
  • Özten N, Horton L, Lasano S, and Bosland MC: Selenomethionine and α-tocopherol do not inhibit prostate carcinogenesis in the testosterone plus estradiol-treated NBL rat model. Cancer Prev Res 3, 371–380, 2010.
  • McCormick DL, Rao KV, Dooley L, Steele VE, Lubet RA, et al.: Influence of N-methyl-N-nitrosourea, testosterone, and N-(4-hydroxyphenyl)-all-trans-retinamide on prostate cancer induction in Wistar-Unilever rats. Cancer Res 58, 3282–3288, 1998.
  • Bosland MC, Ford H, and Horton L: Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17 beta or diethylstilbestrol. Carcinogenesis 16, 1311–1317, 1995.
  • Ofner P, Bosland MC, and Vena RL: Differential effects of diethylstilbestrol and estradiol-17 beta in combination with testosterone on rat prostate lobes. Toxicol Appl Pharmacol 112, 300–309, 1992.
  • Chen W, Wang D, Wang LS, Bei D, Wang J, et al.: Pharmacokinetics of protocatechuic acid in mouse and its quantification in human plasma using LC-tandem mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 908, 39–44, 2012.
  • Eskra JN, Schlicht MJ, and Bosland MC: Effects of black raspberries and their ellagic acid and anthocyanin constituents on taxane chemotherapy of castration-resistant prostate cancer cells. Sci Rep 9, 4367, 2019.
  • Guadamillas MC, Cerezo A, and Del Pozo MA: Overcoming anoikis–pathways to anchorage-independent growth in cancer. J Cell Sci 124, 3189–3197, 2011.
  • Taddei ML, Giannoni E, Fiaschi T, and Chiarugi P: Anoikis: an emerging hallmark in health and diseases. J Pathol 226, 380–393, 2012.
  • Wang LS, Arnold M, Huang YW, Sardo C, Seguin C, et al.: Modulation of genetic and epigenetic biomarkers of colorectal cancer in humans by black raspberries: a phase I pilot study. Clin Cancer Res 17, 598–610, 2011.
  • Bi X, Fang W, Wang LS, Stoner GD, and Yang W: Black raspberries inhibit intestinal tumorigenesis in Apc1638+/- and Muc2-/- mouse models of colorectal cancer. Cancer Prev Res 3, 1443–1450, 2010.
  • Yamaguchi H, Wyckoff J, and Condeelis J: Cell migration in tumors. Curr Opin Cell Biol 17, 559–564, 2005.
  • Friedl P and Wolf K: Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3, 362–374, 2003.
  • Labrecque L, Lamy S, Chapus A, Mihoubi S, Durocher Y, et al.: Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary-derived phenolic compound. Carcinogenesis 26, 821–826, 2005.
  • Medda R, Lyros O, Schmidt JL, Jovanovic N, Nie L, et al.: Anti-inflammatory and anti-angiogenic effect of black raspberry extract on human esophageal and intestinal microvascular endothelial cells. Microvasc Res 97, 167–180, 2015.
  • Nemeth K, Plumb GW, Berrin JG, Juge N, Jacob R, et al.: Deglycosylation by small intestinal epithelial cell beta-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. Eur J Nutr 42, 29–42, 2003.
  • Kakkar S, and Bais S: A review on protocatechuic acid and its pharmacological potential. ISRN Pharmacol 2014, 952943, 2014.
  • Singletary K and Liao CH: Ellagic acid effects on the carcinogenicity, DNA-binding and metabolism of 7,12-dimethylbenz(a)anthracene (DMBA). In Vivo 3, 173–175, 1989.
  • Larrosa M, Gonzalez-Sarrias A, Garcia-Conesa MT, Tomas-Barberan FA, and Espin JC: Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities. J Agric Food Chem 54, 1611–1620, 2006.
  • Schmitt E and Stopper H: Estrogenic activity of naturally occurring anthocyanidins. Nutr Cancer 41, 145–149, 2001.
  • Tam NN, Leav I, and Ho SM: Sex hormones induce direct epithelial and inflammation-mediated oxidative/nitrosative stress that favors prostatic carcinogenesis in the noble rat. Am J Pathol 171, 1334–1341, 2007.
  • Ozten N, Vega K, Liehr J, Huang X, Horton L, et al.: Role of estrogen in androgen-induced prostate carcinogenesis in NBL rats. Horm Cancer 10, 77–88, 2019.
  • Youdim KA, Martin A, and Joseph JA: Incorporation of the elderberry anthocyanins by endothelial cells increases protection against oxidative stress. Free Radic Biol Med 29, 51–60, 2000.
  • Lazzé MC, Pizzala R, Savio M, Stivala LA, Prosperi E, et al.: Anthocyanins protect against DNA damage induced by tert-butyl-hydroperoxide in rat smooth muscle and hepatoma cells. Mutat Res 535, 103–115, 2003.
  • Castañeda-Ovando A, Pacheco-Hernández ML, Páez-Hernández ME, Rodríguez JA, and Galán-Vidal CA: Chemical studies of anthocyanins: a review. Food Chem 113, 859–871, 2009.
  • He J and Giusti MM: Anthocyanins: natural colorants with health-promoting properties. Annu Rev Food Sci Technol 1, 163–187, 2010.
  • Faria A, Fernandes I, Calhau C, de Freitas V, and Mateus N: Bioavailability of anthocyanins and derivatives. J Funct Foods 7, 54–66, 2014.
  • Faria A, Fernandes I, Norberto S, Mateus N, and Calhau C: Interplay between anthocyanins and gut microbiota. J Agric Food Chem 62, 6898–6902, 2014.
  • Keppler K and Humpf HU: Metabolism of anthocyanins and their phenolic degradation products by the intestinal microflora. Bioorg Med Chem 13, 5195–5205, 2005.
  • Kamiloglu S, Capanoglu E, Grootaert C, and Van Camp J: Anthocyanin absorption and metabolism by human intestinal Caco-2 cells-a review. Int J Mol Sci 16, 21555–21574, 2015.
  • Ludwig IA, Mena P, Calani L, Borges G, Pereira-Caro G, et al.: New insights into the bioavailability of red raspberry anthocyanins and ellagitannins. Free Radic Biol Med 89, 758–769, 2015.
  • Ichiyanagi T, Shida Y, Rahman MM, Hatano Y, and Konishi T: Extended glucuronidation is another major path of cyanidin 3-O-beta-D-glucopyranoside metabolism in rats. J Agric Food Chem 53, 7312–7319, 2005.
  • Ichiyanagi T, Shida Y, Rahman MM, Hatano Y, Matsumoto H, et al.: Metabolic pathway of cyanidin 3-O-beta-D-glucopyranoside in rats. J Agric Food Chem 53, 145–150, 2005.
  • Woodward GM, Needs PW, and Kay CD: Anthocyanin-derived phenolic acids form glucuronides following simulated gastrointestinal digestion and microsomal glucuronidation. Mol Nutr Food Res 55, 378–386, 2011.
  • He J, Wallace TC, Keatley KE, Failla ML, and Giusti MM: Stability of black raspberry anthocyanins in the digestive tract lumen and transport efficiency into gastric and small intestinal tissues in the rat. J Agric Food Chem 57, 3141–3148, 2009.
  • Felgines C, Texier O, Garcin P, Besson C, Lamaison JL, et al.: Tissue distribution of anthocyanins in rats fed a blackberry anthocyanin-enriched diet. Mol Nutr Food Res 53, 1098–1103, 2009.
  • Marczylo TH, Cooke D, Brown K, Steward WP, and Gescher AJ: Pharmacokinetics and metabolism of the putative cancer chemopreventive agent cyanidin-3-glucoside in mice. Cancer Chemother Pharmacol 64, 1261–1268, 2009.
  • Stoner GD, Sardo C, Apseloff G, Mullet D, Wargo W, et al.: Pharmacokinetics of anthocyanins and ellagic acid in healthy volunteers fed freeze-dried black raspberries daily for 7 days. J Clin Pharmacol 45, 1153–1164, 2005.
  • Seeram NP, Zhang Y, McKeever R, Henning SM, Lee RP, et al.: Pomegranate juice and extracts provide similar levels of plasma and urinary ellagitannin metabolites in human subjects. J Med Food 11, 390–394, 2008.
  • Zhao M, Tang SN, Marsh LJ, Shankar S, and Srivastava RK: Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice. Cancer Lett 337, 210–217, 2013.
  • Huang ST, Yang RC, Wu HT, Wang CN, and Pang JH: Zinc-chelation contributes to the anti-angiogenic effect of ellagic acid on inhibiting MMP-2 activity, cell migration and tube formation. PLoS One 6, e189862011.
  • Pitchakarn P, Chewonarin T, Ogawa K, Suzuki S, Asamoto M, et al.: Ellagic acid inhibits migration and invasion by prostate cancer cell lines. Asian Pac J Cancer Prev 14, 2859–2863, 2013.
  • Bala I, Bhardwaj V, Hariharan S, and Kumar MN: Analytical methods for assay of ellagic acid and its solubility studies. J Pharm Biomed Anal 40, 206–210, 2006.
  • Karakaya S: Bioavailability of phenolic compounds. Crit Rev Food Sci Nutr 44, 453–464, 2004.
  • Zafrilla P, Ferreres F, and Tomás-Barberán FA: Effect of processing and storage on the antioxidant ellagic acid derivatives and flavonoids of red raspberry (Rubus idaeus) jams. J Agric Food Chem 49, 3651–3655, 2001.
  • Seeram NP, Aronson WJ, Zhang Y, Henning SM, Moro A, et al.: Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland. J Agric Food Chem 55, 7732–7737, 2007.
  • González-Sarrías A, Giménez-Bastida JA, García-Conesa MT, Gómez-Sánchez MB, García-Talavera NV, et al.: Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice. Mol Nutr Food Res 54, 311–322, 2010.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.